Skip to main content
Carrie L. Byington

Carrie L. Byington, MD

Languages spoken: English, Spanish

Academic Information

Departments Emeritus - Pediatrics

Divisions: General Pediatrics

Academic Office Information

Research Interests

  • Infectious Disease
  • Streptococcus pneumoniae

Dr. Byington's research focuses on viral and bacterial infections in infants and children. Research has included the development of new diagnostics, the clinical validation of diagnostics, epidemiology of infectious diseases using molecular diagnostics, and improving health services, including public health, through accurate diagnostics and informatics. The primary pathogens studied include enteroviruses, respiratory viruses particularly influenza and bacterial pathogens including Streptococcus pneumoniae and Neisseria meningitidis. Dr. Byington has several active NIH and CDC grants that support her work. She mentor undergraduates, medical students, residents, fellows and junior faculty conducting clinical and translational research. She is the Director of several Career Development Programs in Pediatrics. She has mentored over 90 trainees and junior faculty, the majority women and under-represented minorities.

Education History

Certification Univeristy of Utah
Univ of California, San Francisco
Chief Resident Baylor College of Medicine
Chief Resident
Baylor College of Medicine
Internship Baylor College of Medicine
Baylor College of Medicine
Undergraduate Texas A&M University

Selected Publications

Journal Article

  1. Byington C, Keenan H, Phillips JD, Childs R, Wachs E, Berzins MA, Clark K, Torres MK, Abramson J, Lee V, Clark EB (In Press). A matrix mentoring model effectively supports clinical and translational scientists and increases inclusion in biomedical research. Acad Med.
  2. Byington CL, Wilkes J, Korgenski K, Sheng X (2015). Respiratory syncytial virus-associated mortality in hospitalized infants and young children. Pediatrics, 135(1), e24-31.
  3. Byington CL (2014). Vaccines: can transparency increase confidence and reduce hesitancy? Pediatrics, 134(2), 377-9.
  4. Glissmeyer EW, Korgenski EK, Wilkes J, Schunk JE, Sheng X, Blaschke AJ, Byington CL (2014). Dipstick screening for urinary tract infection in febrile infants. Pediatrics, 133(5), e1121-7.
  5. Byington CL, Higgins S, Kaskel FJ, Purucker M, Davis JM, Smoyer WE (2014). The CTSA mentored career development program: supporting the careers of child health investigators. Clin Transl Sci, 7(1), 44-7.
  6. Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT (2013). Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics, 132(3), 421-8.
  7. Holsti M, Adelgais KM, Willis L, Jacobsen K, Clark EB, Byington CL (2013). Developing future clinician scientists while supporting a research infrastructure. Clin Transl Sci, 6(2), 94-7.
  8. Ampofo K, Pavia AT, Stockmann CR, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Byington CL (2011). Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. Pediatr Infect Dis J, 30(12), 1100-3.
  9. Ampofo K, Pavia AT, Stockmann C, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL (2011). The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital through the PCV7 Era. Pediatr Infect Dis J.
  10. Kendall BA, Dascomb KK, Mehta RR, Mason EO, Ampofo K, Pombo DJ, Pavia AT, Byington CL (2011). Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine, 29(49), 9123-6.
  11. Blaschke AJ, Allison MA, Meyers L, Rogatcheva M, Heyrend C, Mallin B, Carter M, Lafleur B, Barney T, Poritz MA, Daly JA, Byington CL (2011). Non-invasive sample collection for respiratory virus testing by multiplex PCR. J Clin Virol, 52(3), 210-4.
  12. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA, Swanson JT, Pediatric Infectious Diseases Society and the Infectious Diseases Society of America (2011). The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis, 53(7), e25-76.
  13. Jhaveri R, Byington CL, Klein JO, Shapiro ED (2011). Management of the non-toxic-appearing acutely febrile child: a 21st century approach. J Pediatr, 159(2), 181-5.
  14. American Academy of Pediatrics, Committee on Infectious Diseases (In Press). Recommendations for prevention and control of influenza in children 2011-2012. Pediatrics.
  15. Baker C, and Byington CL and American Academy of Pediatrics, Committee on Infectious Diseases (In Press). Recommendation for the prevention of perinatal Group B streptococcal disease. Pediatrics.
  16. Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K (2011). Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J, 30(4), 289-94.
  17. (2011). Policy statement--recommended childhood and adolescent immunization schedules--United States, 2011. Pediatrics, 127(2), 387-8.
  18. Byington CL, Kendrick J, Sheng X (2011). Normative cerebrospinal fluid profiles in febrile infants. J Pediatr, 158(1), 33-37.
  19. Ampofo, K, Herbener, A, Blaschke, AJ, Heyrend, C, Portiz, M, Korgenski, K, Rolfs, R, Jain, S, Carvahlo, MD, Pimenta, FC, Daly, J, Mason, EO, Byington, CL (2010). Association of 2009 Pandemic Influenza A (H1N1) infection and increased hospitalization with Parapneumonic Empyema in Children in Utah. Pediatr Infect Dis, (10), 905-9.
  20. Bernstein HH, Starke JR, Committee on Infectious Diseases (2010). Recommendation for mandatory influenza immunization of all health care personnel. Pediatrics, 126(4), 809-15.


  1. Carrie L. Byington, MD (2008). Method for Creating and Using a Treatment Protocol for the Evaluation of the Febrile Infant. U.S. Patent No. 7,461,046. Washington, D.C.:U.S. Patent and Trademark Office.